VELOCIGENE Trademark

Trademark Overview

On Friday, May 7, 2010, a trademark application was filed for VELOCIGENE with the United States Patent and Trademark Office. The USPTO has given the VELOCIGENE trademark a serial number of 85032807. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, December 16, 2021. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The VELOCIGENE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Genetic engineering services, namely, deletion and modification of genes for others, and production of genetically modified animals; genetic research
velocigene

General Information

Serial Number85032807
Word MarkVELOCIGENE
Filing DateFriday, May 7, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, December 16, 2021
Registration Number4007205
Registration DateTuesday, August 2, 2011
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 14, 2010

Trademark Statements

Description of MarkThe mark consists of a design of a stylized upside down "V" on top of another "V" to the left of the wording "VELOCIGENE".
Pseudo MarkVELOCITY GENE
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesGenetic engineering services, namely, deletion and modification of genes for others, and production of genetically modified animals; genetic research

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 13, 2010
Primary Code044
First Use Anywhere DateTuesday, January 31, 2006
First Use In Commerce DateTuesday, January 31, 2006

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Tuesday, May 11, 2010NEW APPLICATION ENTERED
Thursday, May 13, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 15, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Thursday, August 19, 2010ASSIGNED TO EXAMINER
Friday, September 17, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 17, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 30, 2010NON-FINAL ACTION WRITTEN
Thursday, September 30, 2010NON-FINAL ACTION E-MAILED
Thursday, September 30, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 8, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 25, 2010NON-FINAL ACTION WRITTEN
Wednesday, August 25, 2010NON-FINAL ACTION E-MAILED
Wednesday, August 25, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 3, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 17, 2010ASSIGNED TO LIE
Friday, October 8, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 8, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, October 24, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 28, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 5, 2010WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, November 9, 2010PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, November 9, 2010EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 9, 2010EXAMINERS AMENDMENT E-MAILED
Tuesday, November 9, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 9, 2010EXAMINER'S AMENDMENT ENTERED
Tuesday, November 9, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 10, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 14, 2010PUBLISHED FOR OPPOSITION
Tuesday, February 8, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 14, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, June 14, 2011USE AMENDMENT FILED
Tuesday, June 21, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 14, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2011STATEMENT OF USE PROCESSING COMPLETE
Monday, June 27, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, June 28, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 2, 2011REGISTERED-PRINCIPAL REGISTER
Thursday, January 12, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 12, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, January 12, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, June 22, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 6, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 6, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, November 4, 2016TEAS SECTION 8 & 15 RECEIVED
Wednesday, July 14, 2021TEAS SECTION 8 & 9 RECEIVED
Thursday, December 16, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sunday, August 2, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, December 16, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 16, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, December 16, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 30, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 30, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

velocigene genetic production genetically modified research animals others genes engineering services